Medication Helps Protect Insulin Production in Type 1 Diabetes
A drug approved to treat high blood pressure, called verapamil, was found protective in people with type 1 diabetes.
Disparities Found in Use of Pediatric Asthma Care
Black children with asthma accessed community health centers less than White children, while Latino children (who prefer to speak either English or Spanish) were more likely to visit CHCs for acute, chronic and preventive care overall.
Research Shows Dangerous, Growing Trend of Illicit Fentanyl Use
Law enforcement seizures of pills containing illicit fentanyl increased dramatically since 2018, according to a new NIDA-funded study published in Drug and Alcohol Dependence.
Mandatory Masking Reduced Covid-19 Cases in Schools During Delta
Schools with mandatory masking during the Delta surge had approximately 72 percent fewer cases of in-school transmission of SARS-CoV-2 compared with schools with optional or partial masking policies, according to an NIH-funded study
NIH Launches Trials of Three HIV mRNA Vaccines
NIAID has launched a phase 1 clinical trial evaluating three experimental HIV vaccines based on a messenger RNA (mRNA) platform—a technology used in several approved Covid-19 vaccines.
Can Restricting Calories Extend Your Life?
Calorie restriction—reducing food intake without causing malnutrition—can yield health benefits that include improved metabolism and delayed onset of age-associated diseases.
Scientists Discover New Molecular Pathway Shared by Two Neurodegenerative Disorders
Scientists from two independent research teams have discovered how the mislocalization of a protein, known as TDP-43, alters the genetic instructions for UNC13A, providing a possible therapeutic target that could have implications in treating amyotrophic lateral sclerosis (ALS), frontotemporal dementia (FTD) and other forms of dementia.
Scientists Pinpoint Mechanisms Associated with Severe Covid-19 Blood Clotting
After studying blood samples from 244 patients hospitalized for Covid-19, a group of researchers, including NIH investigators, identified “rogue antibodies” that correlate with severe illness and may help explain mechanisms associated with severe blood clotting.